2.Current situation and challenges on the implementation of prevention and control programs regarding the seasonal influenza, in China.
J D ZHENG ; Z B PENG ; Y QIN ; L Z FENG ; Z J LI
Chinese Journal of Epidemiology 2018;39(8):1041-1044
In China, the control and prevention programs on any disease has always been based on comprehensive strategies. Take influenza as an example, related contents would include: strengthening the surveillance, recommendation and promotion of vaccination, rational use of antiviral drugs, conducting outbreak investigation and control, and publicizing individual protective measures, etc. In terms of the response to challenges, specific proposals would include: adjustment of case reports, optimization of surveillance systems, reinforcement of vaccination recommendation by health care workers, improvement of access to vaccination, development of rapid diagnostic reagents, and rational use of antiviral drugs, etc.
Antiviral Agents/therapeutic use*
;
China/epidemiology*
;
Disease Outbreaks/prevention & control*
;
Health Personnel
;
Humans
;
Influenza Vaccines/administration & dosage*
;
Influenza, Human/prevention & control*
;
Primary Prevention/organization & administration*
;
Program Development
;
Seasons
;
Vaccination
3.Bibliometric analysis on research hotspots on HIV post-exposure prophylaxis related articles in the world, 2000-2017.
T Y LU ; X MAO ; E L PENG ; J M LI ; W Q GENG ; Y J JIANG ; J J XU
Chinese Journal of Epidemiology 2018;39(11):1501-1506
Objective: To analyze and reveal the distribution, research hotspots and study trend of worldwide published articles correlated with HIV/AIDS post-exposure prophylaxis (PEP), and provide information for related studies in China. Methods: CiteSpace software 5.1 was used to visualize all related papers in the web of science database published during 2000-2017. Results: The average growth rate of international PEP-related papers was 10.78%,and number of published papers in 2016 was highest (n=34), relevant research hotspots have shifted from the prevention of occupational HIV exposure to the prevention of non-occupational HIV exposure in group at high risk, such as MSM, in recent years. Clustering analysis classified research hotspots into three categories, including risk reduction through enhanced intervention, current status of global HIV PEP and German-Austrian Recommendation. Conclusions: Non-occupational HIV PEP in groups at high-risk, especially MSM, has received increasing attention in recent years, the research of PEP mainly focus on improving the awareness and use of PEP in MSM and compliance in the course of medication. In the context of severe HIV epidemic in MSM without effective control in China, PEP should be strengthened to assess and explore the risk of HIV infection in MSM to provide reference for medical personnel and related departments to implement HIV non-occupation exposure blockade and formulate PEP medication.
Anti-HIV Agents/administration & dosage*
;
Bibliometrics
;
Biomedical Research
;
China
;
HIV
;
HIV Infections/prevention & control*
;
Homosexuality, Male
;
Humans
;
Male
;
Periodicals as Topic
;
Post-Exposure Prophylaxis/methods*
4.Study on the super-antigen genes of group A Streptococcus pyogenes strains isolated from patients with scarlet fever and pharyngeal infection, in Beijing, 2015-2017.
C N MA ; X M PENG ; S S WU ; D T ZHANG ; J C ZHAO ; G L LU ; Y PAN ; S J CUI ; Y M LIU ; W X SHI ; M ZHANG ; Q Y WANG ; P YANG
Chinese Journal of Epidemiology 2018;39(10):1375-1380
Objective: To analyze the characteristics of super-antigen (SAg) of group A Streptococcus pyogenes (GAS), isolated from patients with scarlet fever or pharyngeal infections in Beijing between 2015-2017. Methods: Throat swab specimens from patients with scarlet fever or pharyngeal infections were collected and tested for GAS. Eleven currently known SAg genes including SpeA, speC, speG, speH, speI, speJ, speK, speL, speM, smeZ and ssa were tested by real-time PCR while M protein genes (emm genes) were amplified and sequenced by PCR. Results: A total of 377 GAS were isolated from 6 801 throat swab specimens, with the positive rate as 5.5%. There were obvious changes noticed among speC, speG, speH and speK in three years. A total of 45 SAg genes profiles were observed, according to the SAgs inclusion. There were significant differences appeared in the frequencies among two of the highest SAg genes profiles between emm1 and emm12 strains (χ(2)=38.196, P<0.001; χ(2)=72.310, P<0.001). There also appeared significant differences in the frequencies of speA, speH, speI and speJ between emm1 and emm12 strains (χ(2)=146.154, P<0.001; χ(2)=52.31, P<0.001; χ(2)=58.43, P<0.001; χ(2)=144.70, P<0.001). Conclusions: Obvious changes were noticed among SAg genes including speC, speG, speH and speK from patients with scarlet fever or pharyngeal infections in Beijing between 2015-2017. SAg genes including speA, speH, speI and speJ appeared to be associated with the emm 1 and emm 12 strains. More kinds of SAg genes profiles were isolated form GAS but with no significant differences seen in the main SAg genes profiles, during the epidemic period.
Antigens, Bacterial/genetics*
;
Bacterial Outer Membrane Proteins
;
Bacterial Proteins
;
Beijing/epidemiology*
;
China/epidemiology*
;
Exotoxins
;
Female
;
Humans
;
Membrane Proteins
;
Pharyngitis/microbiology*
;
Pharynx/microbiology*
;
Pregnancy
;
Pregnancy Complications, Infectious/microbiology*
;
Real-Time Polymerase Chain Reaction
;
Scarlet Fever/microbiology*
;
Streptococcal Infections
;
Streptococcus pyogenes/isolation & purification*
;
Superantigens/genetics*
5.Diagnostic and epidemiological features of the first two HIV-2 indigenous infections in Hunan province.
J Y PENG ; J ZHENG ; J M HE ; Y JIANG ; D YAO ; X CHEN
Chinese Journal of Epidemiology 2018;39(8):1077-1081
Objective: To study the diagnostic and epidemiological features of the first two HIV-2 indigenous cases in Hunan province. Methods: Blood samples from two individuals with "HIV antibody indeterminate" and HIV-2 specific band showed by HIV-1/2 western blotting method, were repeatedly collected and detected under HIV 1+2 strip immunoassay and PCR, in Changsha city, Hunan province, through March to November, 2017. An epidemiological survey was carried out at the same time. Results: Our findings showed that the two cases were sex partners, without histories of sexual contact with foreigners and the source of infection was unknown. Results from the HIV 1+2 antibody confirmation test showed that they were "HIV-2 antibody positive" . Through amplifying and sequencing the gag area of HIV-2 and BLAST, the similarity of HIV-2 strains presented as 98%. The results also showed that there were HIV-2 specific fragments in the two cases. Conclusion: HIV-2 indigenous cases had never been reported in China. These cases had brought new challenge on prevention, diagnosis and treatment of HIV/AIDS in China.
Adult
;
Blotting, Western/methods*
;
China
;
HIV Antibodies/isolation & purification*
;
HIV Infections/ethnology*
;
HIV-2/immunology*
;
Humans
;
Sexual Behavior
;
Sexual Partners
;
Surveys and Questionnaires
6.History of influenza pandemics in China during the past century.
Y QIN ; M J ZHAO ; Y Y TAN ; X Q LI ; J D ZHENG ; Z B PENG ; L Z FENG
Chinese Journal of Epidemiology 2018;39(8):1028-1031
Five influenza pandemics had occurred during the past century (1918 "Spanish flu" , 1957 "Asian flu" , 1968 "Hong Kong flu" , 1977 "Russian flu" and 2009 H1N1 Pandemic), accounting for hundreds of millions of people infected and tens of millions dead. China was influenced by all the five pandemics, and three of them (1957 "Asian flu" , 1968 "Hong Kong flu" and 1977 "Russian flu" ) were originated from China. The pandemics triggered the establishment of public health agencies and influenza surveillance capacities. In addition, more resources were allocated to influenza-related research, prevention and control. As a leader in the field of influenza, China should further strengthen its pandemic preparedness and response to contribute to global health.
Asian People
;
China/epidemiology*
;
Disease Outbreaks/history*
;
History, 20th Century
;
History, 21st Century
;
Hong Kong
;
Humans
;
Influenza A Virus, H1N1 Subtype
;
Influenza, Human/history*
;
Pandemics/history*
;
Public Health
8.Chinese burn referral criteria (2018 version).
Chinese Burn Association ; Society of Burn Surgery of Chinese Medical Doctor Association ; Editorial Committee of Chinese Journal of Burns ; Burn Medicine Branch of China International Exchange and Promotion Association for Medical and Healthcare ; Burn and Trauma Branch of Chinese Geriatrics Society ; G X LUO ; Z Q YUAN ; Y Z PENG ; J WU ; Y S HUANG
Chinese Journal of Burns 2018;34(11):E001-E001
There is no national referral criteria for burns in China till now, which brings inconvenience and confusion. Based on the oversea experiences and the actual situation in China, many famous experts on burns discussed and developed this Chinese burn referral criteria (2018 version). We hope these referral criteria will be helpful in clinical practice in burn field and can be improved continuously during application.
Burn Units
;
standards
;
Burns
;
therapy
;
China
;
Humans
;
Practice Guidelines as Topic
;
standards
;
Referral and Consultation
;
standards
9.Current situation and related policies on the implementation and promotion of influenza vaccination, in China.
Z B PENG ; D Y WANG ; J YANG ; P YANG ; Y Y ZHANG ; J CHEN ; T CHEN ; Y M ZHENG ; J D ZHENG ; S Q JIANG ; L L XU ; M KANG ; Y QIN ; M J ZHAO ; Z J LI ; L Z FENG
Chinese Journal of Epidemiology 2018;39(8):1045-1050
Influenza can be prevented through annual appropriate vaccination against the virus concerned. In China, influenza vaccine is categorized as "Class Ⅱ" infectious diseases which the cost is paid out of the user's pockets. The annual coverage of influenza vaccination had been 2%-3%. The main reasons for the low coverage would include the following factors: lacking awareness on both the disease and vaccine, poor accessibility of vaccination service, and the cost of vaccination. To reduce the health and economic burden associated with influenza, comprehensive policies should be improved, targeting the coverage of seasonal influenza vaccination. These items would include: ① Different financing reimbursement schemes and mechanisms to improve the aspiration on vaccination and on the vaccine coverage in high-risk groups, as young children, elderly, people with underlying medical conditions; ② to ameliorate equality of vaccination services; ③ to improve knowledge of the health care workers (HCWs) and the public on influenza and related vaccines; ④ to improve clinical and preventive medical practice and vaccination among HCWs through revising clinical guidelines, pathway and consensus of experts; ⑤ to provide more convenient, accessible and normative vaccination service system; ⑥ to strengthen research and development as well as marketing on novel influenza vaccines; ⑦ to revise items regarding the contraindication for influenza vaccine on pregnancy women, stated in the Chinese Pharmacopoeia.
Aged
;
Awareness
;
Child
;
China
;
Costs and Cost Analysis
;
Female
;
Health Knowledge, Attitudes, Practice
;
Health Personnel
;
Health Promotion/methods*
;
Humans
;
Influenza Vaccines/economics*
;
Influenza, Human/prevention & control*
;
Male
;
Pregnancy
;
Vaccination
10.Technical guidelines for seasonal influenza vaccination in China, 2018-2019.
L Z FENG ; Z B PENG ; D Y WANG ; P YANG ; J YANG ; Y Y ZHANG ; J CHEN ; S Q JIANG ; L L XU ; M KANG ; T CHEN ; Y M ZHENG ; J D ZHENG ; Y QIN ; M J ZHAO ; Y Y TAN ; Z J LI ; Z J FENG
Chinese Journal of Epidemiology 2018;39(11):1413-1425
Seasonal influenza vaccination is the most effective way to prevent influenza virus infection and its complications. Currently, China has licensed trivalent (IIV3) and quadrivalent inactivated influenza vaccine (IIV4), including split-virus influenza vaccine and subunit vaccine. In most parts of China, influenza vaccine is a category Ⅱ vaccine, which means influenza vaccination is voluntary, and recipients need to pay for it. To strengthen the technical guidance for prevention and control of influenza and the operational research on influenza vaccination in China, the National Immunization Advisory Committee (NIAC), Influenza Vaccine Technical Working Group (TWG), updated the 2014 technical guidelines and compiled the "Technical guidelines for seasonal influenza vaccination in China (2018-2019)" , based on most recent existing scientific evidences. The main updates include: epidemiology and disease burden of influenza, types of influenza vaccines, northern hemisphere influenza vaccination composition for the 2018-2019 season, and, IIV3 and IIV4 vaccines'major immune responses, durability of immunity, immunogenicity, vaccine efficacy, effectiveness, safety, cost-effectiveness and cost-benefit. The recommendations include: Points of Vaccination clinics (PoVs) should provide influenza vaccination to all persons aged 6 months and above who are willing to be vaccinated and do not have contraindications. No preferential recommendation is made for any influenza vaccine product for persons who can accept ≥1 licensed, recommended, and appropriate products. To decrease the risk of severe infections and complications due to influenza virus infection among high risk groups, the recommendations prioritize seasonal influenza vaccination for children aged 6-60 months, adults ≥60 years of age, persons with specific chronic diseases, healthcare workers, the family members and caregivers of infants <6 months of age, and pregnant women or women who plan to pregnant during the influenza season. Children aged 6 months to 8 years old require 2 doses of influenza vaccine administered a minimum of 4 weeks apart during their first season of vaccination for optimal protection. If they were vaccinated in previous influenza season, 1 dose is recommended. People ≥ 9 years old require 1 dose of influenza vaccine. It is recommended that people receive their influenza vaccination by the end of October. Influenza vaccination should be offered as soon as the vaccination is available. Influenza vaccination should continue to be available for those unable to be vaccinated before the end of October during the whole season. Influenza vaccine is also recommended for use in pregnant women during any trimester. These guidelines are intended for CDC members who are working on influenza control and prevention, PoVs members, healthcare workers from the departments of pediatrics, internal medicine, and infectious diseases, and members of maternity and child care institutions at all levels.
Adult
;
Child
;
Child, Preschool
;
China
;
Female
;
Guidelines as Topic
;
Humans
;
Infant
;
Influenza Vaccines/administration & dosage*
;
Influenza, Human/prevention & control*
;
Pregnancy
;
Seasons
;
Vaccination